RE: Covid 19 a Vascular Disease aswell.17 Oct 2021 15:20
Thanks for all the replies. So I’m assuming there could be benefit. Would that mean another trial would need to be conducted to measure reduced heart inflammation with SNG patients.
I guess I’m trying to ask is if P3 sprinter goes well would another trial have to happen to specifically measure this ?
Sorry if it’s a dumb question